Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 479 (LINC00479) is a non-coding RNA gene classified as a long non-coding RNA (lncRNA). It does not encode a protein, and there is currently no evidence that it functions as a therapeutic target (such as receptor, enzyme, transporter, etc.). Its biological roles and disease associations are not well characterized in public scientific resources. Alternative names include FLJ32835, PRED76, and C21orf129[1][3][5][7][10].\n\nNotes:\n- LINC00479 is not a conventional drug target (e.g., receptor, enzyme) but is rather a genetic locus for a long non-coding RNA[5][10].\n- There is no evidence from current databases or literature indicating use in therapy, drug interaction, or biomarker status.\n- Information is limited; some databases list only basic genomic annotations without functional characterization[1][3][5][7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 479 (LINC00479).